Broadcasts.com - browse "Science" podcasts

Published: Nov. 21, 2023, 5 a.m.
Duration: N/A

Listed in: Science

Hyperkalemia in CKD and HFrEF...What Am I Missing?

Published: Nov. 17, 2023, 5 a.m.
Duration: N/A

Listed in: Science

Revolutionary Approaches to Improving Outcomes in Unresected LA SCCHN

Published: Nov. 15, 2023, 5 a.m.
Duration: N/A

Listed in: Science

Keeping Pace in Lung Cancer HER2: Unveiling New Horizons in NSCLC Treatment

Published: Nov. 15, 2023, 5 a.m.
Duration: N/A

Listed in: Science

Lets Rewind: Recognizing NAFLD/NASH in the Primary Care Clinic

Published: Nov. 14, 2023, 5 a.m.
Duration: N/A

Listed in: Science

Advances in Minimally Invasive Screening for Lung Cancer: Breaking Data from Honolulu

Published: Nov. 10, 2023, 5 a.m.
Duration: N/A

Listed in: Science

Clinical Implications of the Evidence from IV Iron Trials in Heart Failure

Published: Nov. 3, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Overview of New ERS/ESC Guideline Recommendations

Published: Oct. 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Management of PAH: Update on the Therapeutic Landscape

Published: Oct. 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case Study: CTEPH

Published: Oct. 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Diagnosis & Treatment of Chronic Thromboembolic Pulmonary Hypertension

Published: Oct. 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Focus on CTEPH/CTED

Published: Oct. 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case Study: Group 3 PH Pulmonary Hypertension Due to Chronic Lung Disease

Published: Oct. 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Link Between Parenchymal Lung Disease and PH

Published: Oct. 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Focus on Lung-Disease Associated PH

Published: Oct. 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case Study: CTD-PAH

Published: Oct. 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Pulmonary Hypertension in Rheumatic Diseases - Part 2

Published: Oct. 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Focus on CTD-PAH and Rheumatology

Published: Oct. 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Video Demo: Cardiopulmonary Exercise Testing in Pulmonary Arterial Hypertension - Part 2

Published: Oct. 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case Study: CPET

Published: Oct. 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

MET Inhibition in Metastatic NSCLC In the Spotlight

Published: Oct. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Gout Beyond the Joints: Whats the Hidden Danger?

Published: Oct. 24, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Is Gout Hiding in the Nephrology Clinic?

Published: Oct. 24, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Is Managing Gout in the Nephrology Clinic a Challenge?

Published: Oct. 24, 2023, 4 a.m.
Duration: N/A

Listed in: Science

2023 ESC Guideline Updates: Where Are We with Iron Deficiency?

Published: Oct. 20, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Medication Overuse Headache

Published: Oct. 20, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Migraine Treatment Update 2023

Published: Oct. 20, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Novel and Emerging Chronic Migraine Therapies

Published: Oct. 20, 2023, 4 a.m.
Duration: N/A

Listed in: Science

New Insights on Integrating Chronic Migraine Preventatives in Clinical Practice

Published: Oct. 20, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Identification and Management of Tardive Dyskinesia

Published: Oct. 19, 2023, 4 a.m.
Duration: N/A

Listed in: Science

A Practical Look at Cardiorenal Protection for CKD in T2D: Applying Recent Data

Published: Oct. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Targeting TSLP in Severe Asthma: A Case-Based Exploration for the Pulmonologist

Published: Oct. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Putting It Into Practice: Where Do S1P Receptor Modulators Fit?

Published: Oct. 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Improving Management of Atopic Dermatitis in Children and Adults with Novel Therapies

Published: Oct. 16, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Enhancing Care in Moderate to Severe Psoriasis: Treatment Selection

Published: Oct. 16, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Optimizing the Diagnosis and Management of Overactive Bladder in Men and Older Adults

Published: Oct. 16, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Strategies for Mitigating Health Disparities in Patients with Anemia of CKD

Published: Oct. 16, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Optimizing Guideline-Recommended Heart Failure Treatment at Transitions of Care

Published: Oct. 16, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Clinical Implications of Updated Heart Failure Nomenclature Part 2

Published: Oct. 16, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Lysosomal Storage Disorders: Recognizing and Addressing a Group of Rare Conditions

Published: Oct. 10, 2023, 4 a.m.
Duration: N/A

Listed in: Science

A Multidisciplinary Approach to Managing Potassium Levels in Patients with Heart Failure When Optimizing RAASi Therapy in Complex Cases

Published: Oct. 9, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Emergency Medicine and Neurocritical Care: Managing Life-Threatening Bleeding in the ED

Published: Oct. 9, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case Presentation: Management of a Patient with Anticoagulation and Severe Traumatic Injuries

Published: Oct. 9, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Intracranial Hemorrhage: Decreasing Time to Treatment to Improve Outcomes

Published: Oct. 9, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Delivery of an ICH Care Bundle: Illustrative Case

Published: Oct. 9, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Severe Gastrointestinal Bleeding: Who Needs Reversal Or Repletion For Upper GI And Lower GI Bleeding?

Published: Oct. 9, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Who Needs Reversal or Repletion for UGI and LGI Bleeding: Case Presentation

Published: Oct. 9, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Trauma in the Anticoagulated Patient: Decreasing Morbidity and Mortality in Severe Injuries

Published: Oct. 9, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Increasing the Uptake of Flu Vaccines Across the Age and Risk Spectrum

Published: Oct. 4, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Emerging Treatment for Anemia of CKD: HIF-PH Inhibitors

Published: Oct. 4, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Evidence and Guidelines for COVID-19 In-Hospital Management: Putting It All Together

Published: Oct. 3, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Sleep Architecture and Neurotransmitters of Sleep

Published: Sept. 29, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Patient Perspective: Living With Insomnia

Published: Sept. 29, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Exploring the Impact of Insomnia on Daytime Functioning and Cognition

Published: Sept. 29, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Utilizing Assessment Tools in Insomnia

Published: Sept. 29, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Examining Treatment Options for Insomnia: From Orexin to GABA

Published: Sept. 29, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Integrating Evidence and Cultural Sensitivity in Patient-Centric Insomnia Treatments

Published: Sept. 29, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Choosing Between Doublets and Triplets in mHSPC: What Is the Data?

Published: Sept. 29, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Expert Panel: Selecting Treatment in mHSPC: Which Treatment for Which Patient?

Published: Sept. 29, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Expert Panel: How Does ADT Intensification for mHSPC Affect Future Therapy Options?

Published: Sept. 29, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Expert Panel: How Can We Integrate Patient Preference Data To Support Shared Decision-Making Conversations in mHSPC?

Published: Sept. 29, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How Nurses and Advanced Practice Clinicians Can Help Patients Navigate a New mHSPC Diagnosis

Published: Sept. 29, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Is the Pharmacists Role in Managing mHSPC Doublet and Triplet Regimens?

Published: Sept. 29, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Is the Current State of Disparities in Prostate Cancer Care?

Published: Sept. 29, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Can I Do to Improve Care of Prostate Cancer Patients at Risk for Inequities?

Published: Sept. 29, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Challenges in Myelodysplastic Syndromes (MDS): Risk Stratification and Integrating Novel Treatment Approaches

Published: Sept. 26, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Biomarker Testing in NSCLC: Who, What, When?

Published: Sept. 26, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Improving the Odds in Metastatic Castrate-Sensitive Prostate Cancer

Published: Sept. 26, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Introducing Novel Agents Into the Armamentarium for Triple-Negative Breast Cancer

Published: Sept. 26, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Highlights from Singapore on Targeted Therapies in NSCLC

Published: Sept. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Highlights from Singapore on Immunotherapies in Early-Stage NSCLC

Published: Sept. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Highlights from Singapore on Immunotherapies in Metastatic NSCLC

Published: Sept. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Are the Data Supporting First Line C3 Inhibitor Treatment of PNH?

Published: Sept. 22, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Are the Data Supporting First Line C5 Inhibitor Treatment of PNH?

Published: Sept. 22, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Is the Impact of First line PNH Treatment Choice on Risk of Thrombosis

Published: Sept. 22, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Is Long-Term Complement Inhibition Safe and Effective in PNH?

Published: Sept. 22, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Patient Case: How Would You Treat a Newly Diagnosed PNH Patient with Near Normal Hgb?

Published: Sept. 22, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Keeping Up With the Rapid Emergence of Strategies for Advanced Renal Cell Carcinoma

Published: Sept. 20, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What You Should Know About Managing Your Patients with Both CKD and Hyperkalemia

Published: Sept. 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Real-World Treatment of Retinal Disease

Published: Sept. 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Clinical Evidence for Durable Treatment of nAMD

Published: Sept. 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Clinical Evidence for Durable Treatment of DME

Published: Sept. 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Real-World Outcomes with Durable Treatments for Retinal Diseases

Published: Sept. 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

A Closer Look at Real-World Strategies for Treatment-Resistant DME

Published: Sept. 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

A Look at the Numbers: Cost of Durable Treatments in Retinal Disease

Published: Sept. 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Reconsidering the Algorithm: nAMD

Published: Sept. 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Reconsidering the Algorithm: DME

Published: Sept. 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Reconsidering the Algorithm: Treatment-Resistant DME

Published: Sept. 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Bridging the Gap to Care: What You Need to Know About ATTR-CM Amyloidosis

Published: Sept. 13, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Challenges in Recognizing and Diagnosing MCI in AD Earlier

Published: Sept. 8, 2023, 4 a.m.
Duration: N/A

Listed in: Science

New Data on the Pathophysiology of MCI and Dementia

Published: Sept. 8, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Novel and Emerging Disease Modifying Therapies for Mild Cognitive Impairment Due to AD: Efficacy and Safety of New DMTs for MCI

Published: Sept. 8, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Evolving Treatment Paradigms For Mild Cognitive Impairment and Dementia: How New DMTs Will Fit Into Clinical Practice

Published: Sept. 8, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Disparities and Inequities in the Diagnosis and Care of Vulnerable Patient Populations

Published: Sept. 8, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Professional Recommendations of Clinically Validated Tools Used to Diagnose MCI in AD

Published: Sept. 8, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Evidence-Based Discussion of the New and Emerging DMT Treatment Strategies for MCI

Published: Sept. 8, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Expert Opinion on How the New DMTs Fit into Everyday Clinical Practice

Published: Sept. 8, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Is the Totality of Evidence for IV Iron Treatment Outcomes in Patients with Heart Failure?

Published: Sept. 1, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Addressing Patient Management in ASCVD Risk Reduction: A Collaborative Approach

Published: Aug. 30, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Multiple Myeloma At First Relapse: Is My Patient Refractory to Lenalidomide?

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Pomalidomide-Based Regimens in Early Relapse Multiple Myeloma

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Carfilzomib-Based Regimens for Early Relapse Multiple Myeloma

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Is There a Role for Novel BCMA-Directed Cellular Therapies in Early Relapsed Multiple Myeloma?

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Monoclonal Antibody-Based Regimens for Early Relapse Multiple Myeloma

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Managing AE and Patient Intolerance With Combination Therapy in Early Relapse Multiple Myeloma

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Are There Other Novel Approaches or Targeted Therapies for Early Relapse?

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case Study: How Do You Manage First Relapse Multiple Myeloma Following Daratumumab/Lenalidomide/Dexamethasone (DRd)?

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Choosing and Sequencing Regimens in Relapsed Multiple Myeloma

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How to Identify Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnea

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case Study: Adjusting STOP-BANG Screening Criteria for Minority Ethnic Groups

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Negative Impacts of Excessive Daytime Sleepiness Due to Obstructive Sleep Apnea

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

New Treatments for Residual Excessive Daytime Sleepiness in Obstructive Sleep Apnea

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Algorithm for Assessing Excessive Daytime Sleepiness in Obstructive Sleep Apnea

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

The Epidemiology of Sleepiness in Obstructive Sleep Apnea

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Roundtable: Experts Recommend Tools to Diagnose and Monitor Excessive Daytime Sleepiness in Obstructive Sleep Apnea

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Roundtable: Safety and Efficacy Data on New Therapies for Excessive Daytime Sleepiness in Obstructive Sleep Apnea

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Experts Debate: How Novel Excessive Daytime Sleepiness Treatments Fit Into Clinical Practice for Obstructive Sleep Apnea

Published: Aug. 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Opening Statements in the Case of Targeted Versus ICI Adjuvant Treatment of Stage III Melanoma

Published: Aug. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Prosecution: Argument for BRAF/MEK-Targeted Adjuvant Treatment of Stage III Melanoma

Published: Aug. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Defense: Argument for Single Agent ICI Adjuvant Treatment of Stage III Melanoma

Published: Aug. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Closing Arguments in the Case of Targeted Versus ICI Adjuvant Treatment of Stage III Melanoma

Published: Aug. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Opening Statements in the Case of Anti-CTLA-4-based Versus Anti-LAG3-based Frontline Combination ICI Treatment of Stage IV Melanoma

Published: Aug. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Prosecution: Argument for Anti-CTLA-4-based Frontline Combination ICI Treatment of Stage IV Melanoma

Published: Aug. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Defense: Argument for Anti-LAG3-based Frontline Combination ICI Treatment of Stage IV Melanoma

Published: Aug. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Closing Arguments in the Case of Anti-CTLA-4-based Versus Anti-LAG3-based Frontline Combination ICI Treatment of Stage IV Melanoma

Published: Aug. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How Do We Identify Patients with Localized Prostate Cancer Who Are at Increased Risk for Developing Metastatic Disease?

Published: Aug. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Should We Make Active Surveillance More Active for Localized Prostate Cancer?

Published: Aug. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Is the Future of Neoadjuvant ARI Intensification in Localized Prostate Cancer?

Published: Aug. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Can ARIs Be Combined with Radiation Therapy in High-Risk Localized Prostate Cancer?

Published: Aug. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How Are ARIs Being Used to Intensify Therapy for High-Risk Localized Prostate Cancer After Local Therapy?

Published: Aug. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case Study: How Do We Optimize Treatment Adherence with ARIs in Localized Prostate Cancer?

Published: Aug. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Expert Panel: What Is the Future of Early Intensification in Localized Prostate Cancer?

Published: Aug. 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Lowering Burden to Raise Adherence: Optimizing Prophylaxis for Hemophilia A

Published: Aug. 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Setting the Stage: Case Considerations for Bleeding Management in Anticoagulated Patients

Published: Aug. 11, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Anticoagulant-Associated Major Bleeding Is a Significant Problem: How Do I Address?

Published: Aug. 11, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Whats the Best Available Evidence for Reversal of Life-Threatening Bleeds?

Published: Aug. 11, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Newest Emerging Data from ISTH: Andexanet Alfa vs. 4F-PCC?

Published: Aug. 11, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Meaningfulness of ISTH Chart Audit of In-hospital Mortality for ICH?

Published: Aug. 11, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Clinical and Practical Viability of RWE What Now?

Published: Aug. 11, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Hot Topics in Blood-based Cancer Screening: Key Information on Multi-Cancer Early Detection from 2023 Spring Oncology Meetings

Published: Aug. 10, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Improving Symptoms in Patients with HFrEF Using Novel Device Therapy

Published: Aug. 7, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Comparing In-hospital Mortality With Andexanet Alfa Versus 4-Factor Prothrombin Complex Concentrate

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Andexanet Alfa Is Associated With Lower In-Hospital Mortality Compared to 4-Factor Prothrombin Complex Concentrate in Patients With Factor Xa InhibitorRelated Major Bleeding

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Life-Threatening Bleeding in the Anticoagulated Patient: Real World Evidence

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Essential Aspects of the New ERS/ESC Guidelines on PH Treatment: An Overview

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Hot Topics from the New ERS/ESC Guidelines: Definitions and Risk Assessment

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

2022 ERS/ESC PAH Guidelines on Echocardiography

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

2022 ERS/ESC PH Guidelines on Diagnosis

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

2022 ERS/ESC PAH Guidelines on Treatment

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Essential Aspects of the New ERS/ESC Treatment Guidelines: Patients With Comorbidities

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Implications of Aggressive Therapy in PAH Without Comorbidities

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Implications of Aggressive in PAH with comorbidities Therapy: What Does That Mean?

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How Should Cardiopulmonary Comorbidities Influence PH Treatment Strategy?

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case: Using the 2022 ESC/ERS Treatment Algorithm in Older Male Patient with Cardiopulmonary Comorbidities

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Hot Topics from the New ERS/ESC PH Guidelines: Focus on Treatment

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Treatment Approaches to ILD-PH

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Risk Assessment in PAH

Published: July 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

The HPV Vaccine Announcement for Children and Adolescents: HPV Cancer Prevention Starts with You

Published: July 27, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Keeping Pace in Hematologic Malignancies: 2023 Contextualizing the Evidence: Newly Diagnosed AML in Difficult-to-Treat Subtypes

Published: July 24, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Incorporating Scientific Advances into Myelofibrosis Treatment Plans

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Delivering Change: Mechanisms to Address Racial Healthcare Disparities in Multiple Myeloma

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

"Inadequate Response": Suboptimal, Treatment Resistance, and Pseudo Resistance in Individuals with MDD

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

MDD Treatment: Decisions With Switching, Augmenting, or Staying the Course

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Symptom-Based Treatment Using Measurement-Based Care in Patients With MDD

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Novel Therapeutics Treating the Adverse Events From SSRI and SNRI Monotherapy

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

New and Emerging Treatment Strategies for MDD: Addressing Emotional Blunting and Other Adverse Events

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

ADC Targets: Does Positivity Really Matter?

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Which TNBC Patients Are Eligible for ADCs?

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How Do We Apply Evidence Supporting TROP2 Directed ADCs to the Metastatic TNBC Treatment Paradigm?

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Is the Evidence for ADCs in HR-/HER2-Low Metastatic Breast Cancer?

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Metastatic TNBC: Utilizing Biology and Health Disparities to Inform Shared Decision Making

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Factors Impact Use of ADCs in Special Patient Populations with Metastatic TNBC?

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How Are We Addressing Unanswered Questions Around ADCs in Metastatic TNBC?

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Do Patients/Caregivers Need To Know About ADCs in Metastatic TNBC?

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Is the Future of ADCs in Metastatic TNBC?

Published: July 21, 2023, 4 a.m.
Duration: N/A

Listed in: Science

In the Medical Spotlight: Antibody-Drug Conjugates in Advanced HER2-Positive Gastric/Gastroesophageal Junction Cancer

Published: July 20, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Optimizing the Use of Immunotherapy in the First-line Maintenance Setting for Metastatic Urothelial Carcinoma

Published: July 19, 2023, 4 a.m.
Duration: N/A

Listed in: Science

A Changing Approach to TNBC Management: Patients as Partners in Care

Published: July 18, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Which Resected Stage II Melanoma Patients Benefit from Adjuvant ICI Therapy?

Published: July 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Adjuvant Treatment for BRAF+ Stage III Melanoma: A Case Study to Weigh ICI Versus Targeted Therapies

Published: July 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Optimizing Adjuvant Treatment for Stage IV Melanoma Patients Rendered NED After Surgery

Published: July 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How Can We Best Manage irAEs During Adjuvant ICIs for Melanoma? A Case-Based Approach

Published: July 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How Do Patient Characteristics Impact Adjuvant Therapy in All Stages of Resectable Melanoma?

Published: July 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What is the Future of Adjuvant Therapy for Resectable Melanoma?

Published: July 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Are the Clinical and Therapeutic Implications of the Evolving HER2 Testing Landscape?

Published: July 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Are the Data for HER2-Targeted ADCs in HR+/HER2-Low Metastatic Breast Cancer?

Published: July 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Are the Data for TROP2-Targeted ADCs in HR+/HER2-Positive and HER2-Low MBC?

Published: July 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Selection and Sequencing of ADCs in HR+/HER2-Low MBC

Published: July 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Monitoring and Managing Adverse Effects With ADCs in HR+ Breast Cancer: Strategies To Improve Outcomes

Published: July 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How Do Brain Metastases Affect Your Choice of Systemic Treatment in a Patient with HR+/HER2-low MBC?

Published: July 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Who Is the Best Candidate for Sequencing Trastuzumab Detruxtecan (T-DXd) First?

Published: July 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Who Is the Best Candidate for Sequencing Sacituzumab Govitecan Before T-DXd in HR+ Breast Cancer?

Published: July 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Questions and Conundrums: What Is the Future of ADCs in HR+/HER2-Low MBC?

Published: July 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

First-Line Treatment of Adults with Classical Hodgkin Lymphoma

Published: July 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Application of Data from the ECHELON-1 Trial

Published: July 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Individualizing Frontline Treatment

Published: July 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Bispecific Antibodies in FL

Published: July 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Antibody-Drug Conjugates in FL

Published: July 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Clinical Implications of Bispecific Antibodies and Antibody-Drug Conjugates in FL

Published: July 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

NCCN Guideline Updates in DLBCL

Published: July 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Late-Stage Bispecifics and ADCs in DLBCL

Published: July 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Patient Selection for ADCs in First-Line DLBCL

Published: July 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case 1: How Should I Choose Between Single-Agent IO or IO/Chemotherapy in Patients With PD-L1 = 50% and No Driver Mutations?

Published: July 14, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case 2: In a Patient With PD-L1 149%, Should I Use Single Agent IO or Combination IO?

Published: July 14, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case 3: In a PD-L1 Negative Patient, Is There Any Benefit to Using Single Agent IO/Chemotherapy or Dual Agent IO/ Chemotherapy?

Published: July 14, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case 4: In Patients Ineligible for Platinum-Based Chemotherapy, What Is the Ideal IO-Based Approach?

Published: July 14, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case 5: Is There a Role for IO-Based Therapy in KRAS-Mutated NSCLC? What About Patients With Co-mutations in STK11 or KEAP1?

Published: July 14, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case 6: Implementing Current Guidelines and Best Practices for Monitoring and Mitigating Immune-Related Adverse Events

Published: July 14, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Whats the Consensus on Cardiorenal Protection for CKD in T2D?

Published: July 13, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Taking Command of the Treatment of ESA-Refractory, Transfusion-dependent LR-MDS

Published: July 7, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Applying Evidence to Practice: What Can We Learn from Recent Clinical Trials of IV Iron Use in HF?

Published: July 7, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Hyperkalemia: Is It Still a Challenge in 2023?

Published: June 30, 2023, 4 a.m.
Duration: N/A

Listed in: Science

NSCLC Therapy Management and Biomarker Testing

Published: June 30, 2023, 4 a.m.
Duration: N/A

Listed in: Science

New and Emerging Therapies for Complex Epileptic Syndromes

Published: June 30, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Understanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer

Published: June 29, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Emerging Novel PH Therapies: Will They Impact Treatment Strategies?

Published: June 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Sotatercept: A Novel Entity with Promising Potential for Treating PAH

Published: June 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Emerging PH Therapeutics: Vardenafil

Published: June 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Emerging PH Therapeutics: Ralinepag

Published: June 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Emerging Therapeutics: The Potential of Targeting the Serotonin Pathway in PAH

Published: June 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Gene- and Nano-Therapy for PAH: Could This Be the Future?

Published: June 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

The Role of Inhaled Treprostinil For Treatment of PH-ILD

Published: June 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Imatinib for Group 1 PAH

Published: June 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Seralutinib for Treatment of Group 1 PAH

Published: June 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Emerging PH Therapies: How Will They Impact Treatment Strategies?

Published: June 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

The Future of Muscular Dystrophy Management: Updates for Duchenne Muscular Dystrophy

Published: June 27, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Advances in Glaucoma Treatment: Novel Topical Therapies

Published: June 23, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Lessening Glaucoma Treatment Burden with Topical Therapies: The Evidence (Part 2)

Published: June 23, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Lessening Glaucoma Treatment Burden: Sustained-Release Therapies (Part 2)

Published: June 23, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Advances in Glaucoma Treatment: MIGS (Part 1)

Published: June 23, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Advances in Glaucoma Treatment: MIGS (Part 2)

Published: June 23, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Lessening Glaucoma Treatment Burden: Clinical Cases (Part 2)

Published: June 23, 2023, 4 a.m.
Duration: N/A

Listed in: Science

PAH Clinical Consult: Getting to the Heart of PAH

Published: June 20, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Updates in the Field of Non-Advanced Systemic Mastocytosis

Published: June 20, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Are the Recent Updates to Guideline-Driven Care in Non-Advanced Systemic Mastocytosis?

Published: June 20, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How Do You Diagnose and Assess Symptom Burden When Non-Advanced Systemic Mastocytosis Is Suspected?

Published: June 20, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Who Are the Key Players for a Multidisciplinary Approach to Diagnosis and Management of Non-Advanced Systemic Mastocytosis?

Published: June 20, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Rationale for Tyrosine Kinase Inhibitors in Non-Advanced Systemic Mastocytosis

Published: June 20, 2023, 4 a.m.
Duration: N/A

Listed in: Science

When Best Supportive Care Is Not Enough: Who Is Eligible for Targeted Therapy in Non-Advanced Systemic Mastocytosis?

Published: June 20, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Assessing Response to Targeted Therapy in Non-Advanced Systemic Mastocytosis: How to Distinguish AEs From Disease Symptoms

Published: June 20, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Patient-Centered Communications and Shared Decision-Making in the Management of Obesity

Published: June 16, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Non-CF Bronchiectasis (NCFBE): Redefined

Published: June 16, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Non-CF Bronchiectasis (NCFBE): Identifying At-Risk Patients

Published: June 16, 2023, 4 a.m.
Duration: N/A

Listed in: Science

The Neutrophil and Neutrophil Serine Proteases (NSPs) in Non-CF Bronchiectasis (NCFBE)

Published: June 16, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Vortex Management: Diagnostic Algorithm for the PCP and Specialist

Published: June 16, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Vortex Management: Multiprong and Individualized Treatment Approach

Published: June 16, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Caregiver Perspective: A Day in the Life of the Bronchiectasis Patient

Published: June 16, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Caregiver Testimonial: A Day in the Life of the Bronchiectasis Patient

Published: June 16, 2023, 4 a.m.
Duration: N/A

Listed in: Science

The When and How of Implementing New Anti-Neutrophil Therapies Into Standard Clinical Practice

Published: June 16, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Frontline Treatment: A Patient With BRAF WT Metastatic Melanoma - What Is the Optimal ICI Regimen?

Published: June 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How Does Symptom Severity Influence Choice of Frontline Therapy for a Patient with BRAF-Mutated Metastatic Melanoma?

Published: June 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

HPV Vaccination Rates in Mid-Adult and High-Risk Patients: Strategies for Improvement

Published: June 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Can You Use a Dual Checkpoint Inhibitor Regimen in an Unfit Patient With BRAF WT Metastatic Melanoma?

Published: June 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Diagnosis, Management, and Monitoring of IBD: Early Diagnosis and Individualizing Therapy

Published: June 14, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Diagnosis, Management, and Monitoring of IBD: Treat-to-Target and Therapeutic Drug Monitoring

Published: June 14, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Clinical Challenges of IBD Management: Pregnancy Considerations and Shared Decision-Making

Published: June 14, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Clinical Challenges of IBD Management: Biologic Failure and Advances in Surgery

Published: June 14, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Clinical Challenges of IBD Management: A Team-Based Approach to IBD

Published: June 14, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Strategies for Achieving Mucosal Healing

Published: June 14, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Preventing Disease Recurrence with Adjuvant Therapy in Stage IIB/IIC Melanoma

Published: June 9, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Overcoming Barriers for Vulnerable Patients with Diabetic Eye Disease

Published: June 6, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Strategies to Reduce Treatment Burden for Vulnerable Patients with Diabetic Eye Disease

Published: June 6, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Will you ACCELERATE Patient Outcomes?

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Will Lowering the Hemodynamic Threshold for PH Impact Discovery of New Patients?

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Diagnosing PAH: New Emphases on Imaging Modalities

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Echo Aspects are Essential to PH Diagnosis?

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Areas: A Look at the Importance of Physical Measurements of the Right Heart

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Why Arent All Physicians Using Regular and Consistent Risk Assessment Protocols With Their PH Patients?

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Understanding the Proposed 3-Strata Approach for Initial Risk Assessment (RA) at Diagnosis

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Understanding the 4-Strata Approach to Risk Assessment (RA) for Patient Monitoring and Management

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Screening and Diagnosis of PAH: Cardiopulmonary Exercise Testing (CPET)

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case: A 54-Year-Old Woman With Progressive Dyspnea

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

CTD-PAH: What Is the Focus in 2023?

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Why Should We Screen for PAH in Systemic Sclerosis Patients?

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How Do We Screen For PAH in Systemic Sclerosis Patients?

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case: Applying the DETECT Screening Algorithm

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Genetic Testing in PAH: Cascade Genetic Testing Approach

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Phenotyping the ILD-PH Patient To Determine Treatment Strategy

Published: May 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Examining Disparities in Diabetic Eye Health

Published: May 26, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case Challenge in Obesity Medical Management

Published: May 26, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What You Need to Know About Weight-Loss Medications

Published: May 26, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Compassionate Communication: Keeping the Patient and Family Informed Throughout the Patients Journey Through the Four Stages With Rett Syndrome

Published: May 26, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Recognizing the Early and Subtle Signs and Symptoms of Rett Syndrome

Published: May 26, 2023, 4 a.m.
Duration: N/A

Listed in: Science

New Hope: Novel and Emerging Treatment Options for Rett Syndrome

Published: May 26, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Quarterbacking the Interprofessional Team: Optimizing Collaboration and Communication To Enhance Patient Outcome

Published: May 26, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case Study: Diagnosis, Treatment, and Management of Rett Syndrome

Published: May 26, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Living With Rett Syndrome: What to Expect at Each Stage

Published: May 26, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Novel Investigational Treatment Options for Rett Syndrome

Published: May 26, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case Study: Relatively Late Diagnosis & Management of Rett Syndrome

Published: May 26, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimers Disease - Introductory Module

Published: May 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Targeting HER3 in Breast and Lung Cancers: Where We Are and Where We Are Going

Published: May 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Tackling Fluid Overload in Patients with Heart Failure: Novel Approaches to Remote Monitoring

Published: May 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

The Role of Emerging Therapies for Retinal Disease in Clinical Practice

Published: May 15, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case of the Patient in Midlife: Weighing Potential Changes in ASCCP Guidelines

Published: May 12, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection

Published: May 1, 2023, 4 a.m.
Duration: N/A

Listed in: Science

The Impact and Importance of Iron Status

Published: May 1, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Contributors to Iron Status: Serum Ferritin, TSAT, and Hemoglobin

Published: May 1, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Pathogenesis of ID and IDA in Reproductive-Aged Women: Focus on Heavy Menstrual Bleeding

Published: May 1, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Assessing and Addressing ID/IDA: The Need for Guidance

Published: May 1, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How a Womans Iron Status Today Can Impact a Babys Health Tomorrow and Through the Years

Published: May 1, 2023, 4 a.m.
Duration: N/A

Listed in: Science

All Oral Iron Therapies Are Not Created Equal

Published: May 1, 2023, 4 a.m.
Duration: N/A

Listed in: Science

ID and IDA in Postmenopausal Women

Published: May 1, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Strategies to Effectively Manage ID and IDA Throughout the Life Span

Published: May 1, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Iron Supplementation Formulations for Females with ID/IDA: Monitoring Response

Published: May 1, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Enhancing Adherence with Oral Iron Therapy

Published: May 1, 2023, 4 a.m.
Duration: N/A

Listed in: Science

In Any Case? The Importance of Iron Repletion

Published: May 1, 2023, 4 a.m.
Duration: N/A

Listed in: Science

The Role of Radiotherapy in AHOD1331

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Integrating Targeted Therapy Into the Frontline Management of High-Risk Pediatric cHL

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Who May Benefit From Increased Awareness of RSV and Why?

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Supportive Care Only for RSV in 2023 Can We Do Better?

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

RSV Vaccination Lessons From the Past

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

RSV Vaccination and Immunoprophylaxis Optimism for the Future

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Who Is Appropriate for Education and Awareness of RSV?

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Practical Approaches to Addressing Vaccine Hesitancy

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

The Future of Immunoprophylaxis and RSV Vaccines

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Dont Miss the Forest for the Trees: The Challenge of Accurately Identifying the Signs and Symptoms of Agitation in Emergency Settings

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Divergence From the Archaic Norm of Restrain and Sedate Optimization of ER Triage Strategies for Agitated Bipolar Disorder and Schizophrenia Patients

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Shelter from the Storm: The Role and Impact of Pharmacological Treatment Approaches for the Management of Acute Agitation in an Emergency Medicine Setting

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

As Different as Day and Night: Managing Acutely Agitated Patients in the Emergency Setting

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

The Young and the Restless: Meet Crysten Hester

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

From Straps and Needles to Care and Compassion: How to Optimally Manage and De-escalate Agitated BD and SCZ Patients Therapeutically and Non-Pharmacologically

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Treatment Paradigms in the Management of Agitation in BD and SCZ Patients in a Crisis Setting: Evolution of Care for Agitated Patients

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Routine Screening for Psychotic Symptoms in Individuals with Parkinsons Disease Psychosis Leads to Earlier Diagnosis

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Psychotic Symptoms in Parkinsons Disease Psychosis Disrupts Lives: Early Treatment Intervention Makes a Difference

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Develop the Plan, Work the Plan: Integrating Ongoing Patient Assessments for Parkinsons Disease Psychosis

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Parkinsons Disease Psychosis: A Case of Delusions, Diagnosis and Therapeutic Management

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case Study: Aunt Judy Has Been Hallucinating - Treatment Interventions for Parkinsons Disease Psychosis

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

The Building Blocks: Early Recognition, Assessment, and Treatment Intervention for Parkinsons Disease Psychosis

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Expert Recommended Best Practices: Treatment Strategies for Parkinson's Disease Psychosis

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Current Response-Based Treatment of Pediatric Hodgkin Lymphoma

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Integrating Targeted Therapy Into Frontline Management of High-Risk Pediatric Hodgkin Lymphoma

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Managing Toxicities Associated With Anti-CD30 Targeted Therapy in Pediatric and Adolescent Patients

Published: April 28, 2023, 4 a.m.
Duration: N/A

Listed in: Science

The NASH Epidemic: Highlights from the AMCP 2023 Symposium

Published: April 27, 2023, 4 a.m.
Duration: N/A

Listed in: Science

The Oncogenic Significance and Promise of HER3 in Pharmacotherapy

Published: April 25, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Real-World Data Compared to Clinical Practice: Are The Data Replicated in Clinical Practice?

Published: April 24, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Real-World Data Compared to Clinical Practice: Opposing Perspectives

Published: April 24, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Real-World Data and Quality of Evidence in Reversing Anticoagulation: We Believe!

Published: April 24, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Real-World Data and the Quality of Evidence in Reversing Anticoagulation: I'm Not a Skeptic... Just a Purist of Clinical Trials!

Published: April 24, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Bringing It All Together: Real-World Data in Anticoagulation Reversal

Published: April 24, 2023, 4 a.m.
Duration: N/A

Listed in: Science

What Future Studies Are Out There on the Meaningfulness of Reversal in ICH?

Published: April 24, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Better Early Than Late: CDK4/6 Inhibition in HR +, HER2- Early Breast Cancer

Published: April 19, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Special Report: Management Considerations and Unmet Needs in LGS and Dravet Syndrome

Published: April 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Keeping Pace in Lung Cancer Personalizing Treatment in NSCLC: Locally Advanced Disease (Stage IIIB/C)

Published: April 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Epidemiology of AUD and Patient Stratification

Published: April 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Standardized Screening Tools for AUD

Published: April 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How, When, and Why to Conduct Brief AUD Interventions

Published: April 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Assessing a Patients Willingness to Accept Treatment for AUD

Published: April 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Strategies for Referral to AUD Treatment

Published: April 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Selecting an AUD Treatment: Naltrexone

Published: April 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Selecting an AUD Treatment: Acamprosate

Published: April 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Selecting an AUD Treatment: Disulfiram

Published: April 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Selecting an AUD Treatment: Off-Label Agents

Published: April 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Case-Based AUD Challenge

Published: April 17, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Identifying and Assessing Agitation in Alzheimers Dementia

Published: April 11, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Treating Agitation in Alzheimers Dementia

Published: April 11, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Emergency Medicine Perspectives: Targeted vs. Nonspecific Approaches to Anticoagulation Reversal in Real World Analyses for ICH or GI Bleeds

Published: March 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Pharmacy Perspectives: Real-World Management of Factor Xa Inhibitor Associated Bleeding Across 45 US Hospitals

Published: March 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Hematoma Expansion and Clinical Outcomes Comparison in ICH: Clinical Trial Results Versus Real World Care

Published: March 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Bipolar 1 and 2: Distilling the Critical Differences

Published: March 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

How Do You Risk Stratify Bipolar I and II Depression?

Published: March 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

The Journey from Diagnosis to Effective Management of Bipolar I and II Depression

Published: March 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Thinking Out of the Box: Monotherapies versus Adjunctive Therapies in Bipolar I and II Depression

Published: March 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Is It Bipolar Depression or MDD? Diagnostic Criteria

Published: March 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Is It Bipolar Depression or MDD? Treatment Strategies

Published: March 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Challenges with Effective Diagnosis and Management of Bipolar 1 and 2 Depression

Published: March 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Managing Bipolar 1 and 2 Depression: Using Approved Treatments Safely and Effectively

Published: March 31, 2023, 4 a.m.
Duration: N/A

Listed in: Science

UsHERing in New Standards of Care on HER2+ and HER2-Low MBC

Published: March 30, 2023, 4 a.m.
Duration: N/A

Listed in: Science

Advancing Global Care with Emerging BTKi in Relapsed/Refractory CLL: Connecting Hematology Leaders to Worldwide Learners

Published: March 30, 2023, 4 a.m.
Duration: N/A

Listed in: Science